NDC properties for "TOBI Podhaler Daily Kit, 8" (RxCUI 1661567)
About this data
The tables show NDC propoerties for TOBI Podhaler Daily Kit, 8 with the RxCUI 1661567
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for TOBI Podhaler Daily Kit, 8 (RxCUI 1661567)
| NDA | NDA201688 |
|---|---|
| RxCUI | 1661567 |
| SPL_SET_ID | c4b5bb1f-e158-4ac1-9c35-e98a416c743a |
| Prescribable Synonym | TOBI Podhaler 8 Capsule Daily Pack |
| RXNAV_STR | TOBI Podhaler Daily Kit, 8 |
| RxNorm Name | {8 (tobramycin 28 MG Inhalation Powder [Tobi]) } Pack [TOBI Podhaler Daily Kit] |
| RxNorm Synonym | TOBI Podhaler Daily Kit, 8 |
| RxNorm Synonym | TOBI Podhaler Daily Kit, including 8 capsules (1 Blister Card of 8 Capsules) |
| Related queries | Interactions (for RxCUI 1661567) |
NDC Properties
NDC Item 00078063019
| NDC 9 | 0078-0630 |
|---|---|
| NDC 10 | 0078-0630-19 |
| NDC Item | 00078063019 |
| Packaging | 8 in 1 BOX, UNIT-DOSE |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 500733 |
| Imprint code | NVR;AVCI |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2013-03-22 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0078-0630 |
NDC Item 49502034608
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-08 |
| NDC Item | 49502034608 |
| Packaging | 8 in 1 BOX, UNIT-DOSE |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 519453 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-346 |
NDC Item 49502034611
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-11 |
| NDC Item | 49502034611 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 519453 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-346 |
NDC Item 49502040108
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-08 |
| NDC Item | 49502040108 |
| Packaging | 8 CAPSULE in 1 BOX, UNIT-DOSE (49502-401-08) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 49502040109
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-09 |
| NDC Item | 49502040109 |
| Packaging | 8 CAPSULE in 1 BOX, UNIT-DOSE (49502-401-09) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 00078063019
| NDC 9 | 0078-0630 |
|---|---|
| NDC 10 | 0078-0630-19 |
| NDC Item | 00078063019 |
| Packaging | 8 in 1 BOX, UNIT-DOSE |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 500733 |
| Imprint code | NVR;AVCI |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2013-03-22 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0078-0630 |
NDC Item 49502034608
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-08 |
| NDC Item | 49502034608 |
| Packaging | 8 in 1 BOX, UNIT-DOSE |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 519453 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-346 |
NDC Item 49502034611
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-11 |
| NDC Item | 49502034611 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 519453 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-346 |
NDC Item 49502040108
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-08 |
| NDC Item | 49502040108 |
| Packaging | 8 CAPSULE in 1 BOX, UNIT-DOSE (49502-401-08) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 49502040109
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-09 |
| NDC Item | 49502040109 |
| Packaging | 8 CAPSULE in 1 BOX, UNIT-DOSE (49502-401-09) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 00078063019
| NDC 9 | 0078-0630 |
|---|---|
| NDC 10 | 0078-0630-19 |
| NDC Item | 00078063019 |
| Packaging | 8 in 1 BOX, UNIT-DOSE |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 500733 |
| Imprint code | NVR;AVCI |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2013-03-22 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0078-0630 |
NDC Item 49502034608
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-08 |
| NDC Item | 49502034608 |
| Packaging | 8 in 1 BOX, UNIT-DOSE |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 519453 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-346 |
NDC Item 49502034611
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-11 |
| NDC Item | 49502034611 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 519453 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-346 |
NDC Item 49502040108
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-08 |
| NDC Item | 49502040108 |
| Packaging | 8 CAPSULE in 1 BOX, UNIT-DOSE (49502-401-08) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 49502040109
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-09 |
| NDC Item | 49502040109 |
| Packaging | 8 CAPSULE in 1 BOX, UNIT-DOSE (49502-401-09) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 00078063019
| NDC 9 | 0078-0630 |
|---|---|
| NDC 10 | 0078-0630-19 |
| NDC Item | 00078063019 |
| Packaging | 8 in 1 BOX, UNIT-DOSE |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 500733 |
| Imprint code | NVR;AVCI |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2013-03-22 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0078-0630 |
NDC Item 49502034608
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-08 |
| NDC Item | 49502034608 |
| Packaging | 8 in 1 BOX, UNIT-DOSE |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 519453 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-346 |
NDC Item 49502034611
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-11 |
| NDC Item | 49502034611 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 519453 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-346 |
NDC Item 49502040108
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-08 |
| NDC Item | 49502040108 |
| Packaging | 8 CAPSULE in 1 BOX, UNIT-DOSE (49502-401-08) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 49502040109
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-09 |
| NDC Item | 49502040109 |
| Packaging | 8 CAPSULE in 1 BOX, UNIT-DOSE (49502-401-09) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 00078063019
| NDC 9 | 0078-0630 |
|---|---|
| NDC 10 | 0078-0630-19 |
| NDC Item | 00078063019 |
| Packaging | 8 in 1 BOX, UNIT-DOSE |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 500733 |
| Imprint code | NVR;AVCI |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2013-03-22 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 0078-0630 |
NDC Item 49502034608
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-08 |
| NDC Item | 49502034608 |
| Packaging | 8 in 1 BOX, UNIT-DOSE |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 519453 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-346 |
NDC Item 49502034611
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-11 |
| NDC Item | 49502034611 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 519453 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-346 |
NDC Item 49502040108
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-08 |
| NDC Item | 49502040108 |
| Packaging | 8 CAPSULE in 1 BOX, UNIT-DOSE (49502-401-08) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |
NDC Item 49502040109
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-09 |
| NDC Item | 49502040109 |
| Packaging | 8 CAPSULE in 1 BOX, UNIT-DOSE (49502-401-09) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
| Related queries | Properties for NDC 9 49502-401 |